Literature DB >> 11820330

Ventilatory responses to hypercapnia in divers and non-divers: effects of posture and immersion.

P Delapille1, E Verin, C Tourny-Chollet, P Pasquis.   

Abstract

The aim of this study was to determine the effects on respiratory drive of two factors, one mechanical (lung volume) and one chemical (sensitivity to hypercapnia), that are involved in determining the breath-hold duration (BHD). Functional residual capacity was measured by helium dilution with the subject seated in air, seated in water and in the prone position in water. Hyperoxic hypercapnia rebreathing (Read's method) was carried out under identical environmental conditions to assess the effects of CO2 pressure on respiratory centre output by measuring ventilation, mean inspiratory flow and occlusion pressure. Sixteen healthy volunteers were tested. 8 trained divers and 8 non-divers. Functional residual capacity decreased for the postures seated in water (30.8%-34.8%) and for prone position in water (20.3%-20.9%) when compared to the posture seated in air (P<0.0001), all subjects pooled. No difference was found between groups. The slopes of the linear regression, which characterised the sensitivity to CO2 and were determined with the rebreathing tests, revealed differences between the two populations (ventilation: P < 0.0001; mean inspiratory flow: P < 0.05). No difference was found for occlusion pressure or between the different postures. These results confirmed a lower sensitivity to CO2 for trained divers. This adaptation was shown to decrease respiratory centre activity at the origin of the breath-hold breaking point. The immersion, did not influence respiratory drive, despite a decrease in lung volumes. The authors suggest that these findings may be explained by a specific apnoea training and a pronounced bradycardia in immersion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11820330     DOI: 10.1007/s004210100518

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  8 in total

1.  Carotid body chemosensitivity at 1.6 ATA breathing air versus 100% oxygen.

Authors:  Hayden W Hess; David Hostler; Brian M Clemency; Blair D Johnson
Journal:  J Appl Physiol (1985)       Date:  2020-06-25

2.  Adaptation of endurance training with a reduced breathing frequency.

Authors:  Jernej Kapus; Anton Ušaj; Mitch Lomax
Journal:  J Sports Sci Med       Date:  2013-12-01       Impact factor: 2.988

3.  Repeated apneas do not affect the hypercapnic ventilatory response in the short term.

Authors:  Johan P A Andersson; Erika Schagatay
Journal:  Eur J Appl Physiol       Date:  2008-11-19       Impact factor: 3.078

4.  Cerebrovascular reactivity to hypercapnia is unimpaired in breath-hold divers.

Authors:  Vladimir Ivancev; Ivan Palada; Zoran Valic; Ante Obad; Darija Bakovic; Niki M Dietz; Michael J Joyner; Zeljko Dujic
Journal:  J Physiol       Date:  2007-04-05       Impact factor: 5.182

5.  Six weeks of dynamic apnoeic training stimulates erythropoiesis but does not increase splenic volume.

Authors:  Antonis Elia; Matthew J Barlow; Oliver J Wilson; John P O'Hara
Journal:  Eur J Appl Physiol       Date:  2020-12-29       Impact factor: 3.078

Review 6.  Physiology, pathophysiology and (mal)adaptations to chronic apnoeic training: a state-of-the-art review.

Authors:  Antonis Elia; M Gennser; P S Harlow; Matthew J Lees
Journal:  Eur J Appl Physiol       Date:  2021-03-31       Impact factor: 3.078

7.  The Implications of the Diving Response in Reducing Panic Symptoms.

Authors:  Peter Kyriakoulis; Michael Kyrios; Antonio Egidio Nardi; Rafael C Freire; Mark Schier
Journal:  Front Psychiatry       Date:  2021-11-29       Impact factor: 4.157

8.  Diving ergospirometry with suspended weights: breathing- and fin-swimming style matter.

Authors:  Andreas Koch; Dennis Kramkowski; Mattes Holzum; Wataru Kähler; Sebastian Klapa; Bente Rieger; Burkhard Weisser; Jochen D Schipke
Journal:  Eur J Appl Physiol       Date:  2022-08-25       Impact factor: 3.346

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.